Antipodes Partners’s Endava DAVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$376K Buy
132,710
+609
+0.5% +$2.25K 0.01% 93
2026
Q1
$584K Buy
+132,101
New +$729K 0.01% 81

Other funds holding DAVA

Antipodes Partners's DAVA Position: Q2 2026 in Review

Antipodes Partners increased its Endava (DAVA) stake by 0.46% in Q2 2026, buying an estimated $2.25K and bringing the position to 132,710 shares worth $376K. The position accounts for 0.01% of the portfolio, ranked #93.

Antipodes Partners first reported a position in DAVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $584K in Q1 2026. 72 funds tracked by Wall St. Rank hold DAVA as of Q2 2026.

  • Antipodes Partners held 132,710 shares of Endava worth $376K as of Q2 2026.
  • Antipodes Partners bought 609 Endava shares in Q2 2026, an estimated $2.25K.
  • Endava made up 0.01% of Antipodes Partners's portfolio in Q2 2026, its #93 holding.
  • Antipodes Partners first reported a position in Endava in Q1 2026 and has held it in 2 quarters since.
  • Antipodes Partners's Endava position peaked at $584K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Endava as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.